Send us Feedback

BioCryst Pharmaceuticals (BCRX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 31-DEC
2009		 31-MAR
2010
Cash & Equivalents 16.3M 13.8M 18.2M 41.7M 20.5M
Short Term Investments 37.9M 28.4M 17.3M 27.8M 43.2M
Accounts Receivable 9.85M 8.07M 11.6M 33.7M 26.6M
Inventories 0 0 0 6.28M 844K
Pre-paid Expenses 692K 6.74M 3.20M 1.06M 1.27M
Deferred Tax Assets 376K 376K 374K 374K 374K
Other Current Assets 0 0 0 0 0
Total Current Assets 65.1M 57.5M 50.7M 111M 92.8M
Property, Plant & Equipment 4.57M 4.43M 4.17M 3.87M 3.56M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 0 0 3.01M 24.7M 25.8M
Total Long-Term Assets 7.47M 7.24M 9.90M 31.2M 31.9M
Total Assets 72.6M 64.7M 60.6M 142M 125M
Accounts Payable 4.18M 2.79M 3.20M 18.1M 6.35M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 2.59M 2.58M 2.56M 2.55M 2.55M
Total Current Liabilities 13.6M 13.5M 17.7M 37.3M 21.1M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 230K 217K
Other Long-term Liabilities 20.5M 19.9M 19.3M 18.4M 17.8M
Total Long-term Liabilities 20.5M 19.9M 19.3M 18.7M 18.0M
Minority Interest 0 0 0 0 0
Total Liabilities 34.1M 33.4M 37.0M 55.9M 39.1M
Preferred Stock 0 0 0 0 0
Common Par 383K 383K 387K 439K 440K
Additional Paid-In Capital 297M 298M 301M 349M 350M
Retained Earnings -259M -267M -278M -263M -265M
Treasury Stock 0 0 0 0 0
Other Equity 68K 40K 40K -26K 77K
Total Shareholder's Equity 38.5M 31.3M 23.5M 86.3M 85.5M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki